Jefferies Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.2M | Buy |
+34,200
| New | +$4.5M | 0.04% | 382 |
|
|
2022
Q1 | – | Sell |
-24,424
| Closed | -$4.23M | – | 1609 |
|
|
2021
Q4 | $4.23M | Sell |
24,424
-101,500
| -81% | -$15.4M | 0.02% | 520 |
|
|
2021
Q3 | $18.3M | Sell |
125,924
-23,338
| -16% | -$3.41M | 0.13% | 136 |
|
|
2021
Q2 | $19.7M | Buy |
149,262
+144,201
| +2,849% | +$18.9M | 0.12% | 125 |
|
|
2021
Q1 | $650K | Sell |
5,061
-60,987
| -92% | -$7.52M | 0.01% | 1045 |
|
|
2020
Q4 | $7.87M | Buy |
+66,048
| New | +$8.05M | 0.06% | 283 |
|
|
2020
Q2 | – | Sell |
-5,695
| Closed | -$457K | – | 1476 |
|
|
2020
Q1 | $457K | Sell |
5,695
-12,105
| -68% | -$1.25M | 0.01% | 1348 |
|
|
2019
Q4 | $1.9M | Buy |
+17,800
| New | +$1.86M | 0.01% | 1082 |
|
|
2019
Q1 | – | Sell |
-5,161
| Closed | -$430K | – | 2381 |
|
|
2018
Q4 | $430K | Sell |
5,161
-125,317
| -96% | -$11.7M | ﹤0.01% | 1508 |
|
|
2018
Q3 | $14.1M | Buy |
+130,478
| New | +$14.3M | 0.09% | 187 |
|
|
2018
Q2 | – | Sell |
-6,610
| Closed | -$663K | – | 2387 |
|
|
2018
Q1 | $663K | Sell |
6,610
-33,517
| -84% | -$3.43M | ﹤0.01% | 1367 |
|
|
2017
Q4 | $3.95M | Sell |
40,127
-91,157
| -69% | -$8.64M | 0.02% | 655 |
|
|
2017
Q3 | $12.3M | Buy |
131,284
+19,527
| +17% | +$2.07M | 0.08% | 222 |
|
|
2017
Q2 | $12.4M | Buy |
111,757
+869
| +0.8% | +$91.9K | 0.08% | 222 |
|
|
2017
Q1 | $10.9M | Buy |
110,888
+61,973
| +127% | +$5.91M | 0.08% | 241 |
|
|
2016
Q4 | $4.5M | Buy |
48,915
+35,309
| +260% | +$3.04M | 0.03% | 606 |
|
|
2016
Q3 | $1.15M | Buy |
13,606
+6,982
| +105% | +$586K | 0.01% | 1220 |
|
|
2016
Q2 | $539K | Sell |
6,624
-3,355
| -34% | -$255K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $713K | Buy |
+9,979
| New | +$669K | ﹤0.01% | 1278 |
|
|
2015
Q4 | – | Sell |
-23,750
| Closed | -$1.6M | – | 2325 |
|
|
2015
Q3 | $1.46M | Buy |
23,750
+22,555
| +1,887% | +$1.58M | 0.01% | 1035 |
|
|
2015
Q2 | $87K | Buy |
+1,195
| New | +$88.2K | ﹤0.01% | 2248 |
|
|
2014
Q4 | – | Sell |
-8,162
| Closed | -$515K | – | 2006 |
|
|
2014
Q3 | $495K | Sell |
8,162
-18,677
| -70% | -$1.15M | ﹤0.01% | 1337 |
|
|
2014
Q2 | $1.58M | Buy |
26,839
+10,162
| +61% | +$595K | 0.01% | 721 |
|
|
2014
Q1 | $966K | Sell |
16,677
-62,318
| -79% | -$3.34M | 0.01% | 935 |
|
|
2013
Q4 | $4.23M | Buy |
78,995
+60,119
| +318% | +$3.57M | 0.03% | 353 |
|
|
2013
Q3 | $1.17M | Buy |
18,876
+14,190
| +303% | +$849K | 0.01% | 843 |
|
|
2013
Q2 | $284K | Buy |
+4,686
| New | +$279K | ﹤0.01% | 1347 |
|
Other funds holding DGX
Jefferies Group's DGX Position: Q3 2022 in Review
Jefferies Group opened a new position in Quest Diagnostics (DGX) in Q3 2022: 34,200 shares worth $4.2M. The stake represents 0.04% of the portfolio and ranks #382 among its holdings. This is a return to the name: Jefferies Group previously reported a position in DGX as recently as Q4 2021.
Jefferies Group first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. The position peaked at $19.7M in Q2 2021. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Jefferies Group held 34,200 shares of Quest Diagnostics worth $4.2M as of Q3 2022.
- Quest Diagnostics was a new Jefferies Group position in Q3 2022.
- Quest Diagnostics made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #382 holding.
- Jefferies Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
- Jefferies Group's Quest Diagnostics position peaked at $19.7M in Q2 2021.
- 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.